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Bacterial pathogens have evolved ex-
traordinary mechanisms to efficiently in-
fect host organisms. A majority of these
pathogens do so by delivering virulence
factors into host cells, which act to
dampen host defenses or utilize the host
as a niche for replication. Although
regulation of virulence factor expression
by bacterial pathogens is a well known
pathogenic mechanism [1], the concept of
host-protective virulence factors is emerg-
ing. Recently, several strategies by which
pathogens appear to be attenuating their
own lethality towards host cells have been
documented, suggesting that increased
hostility and damage of host cells is not
necessarily beneficial to the pathogen.
Virulence is often defined as the ability
of a pathogen to inflict damage on host
cells, and the following discussion address-
es the concept that increased virulence is
not always beneficial to the pathogen, and
moderating it to preserve host cells is a
mechanism several pathogens use as part
of their overall pathogenic strategy. This
strategy is well known for obligate intra-
cellular pathogens, but has become an
emerging theme in extracellular and
facultative intracellular bacteria.
Yersinia spp., Shigella flexneri, Helicobacter
pylori, and diarrheagenic Escherichia coli are
well known for their ability to kill host
cells. For Yersinia, death of infected mac-
rophages dampens cytokine release and
enables the pathogen to propagate with
minimal challenges from the immune
system [2]. Two recent studies suggest
that cytotoxicity caused by Yersinia species
is tightly regulated. Yersinia pestis, the
etiologic agent of plague, and gastroenter-
itis-inducing Yersinia pseudotuberculosis and
Yersinia enterocolitica all encode a cytotoxic
virulence factor called YopJ/P (YopJ in
the two former species and YopP in the
latter), which are translocated into infected
cells via a type III secretion system (T3SS)
[2,3]. Altering the cytotoxicity of Y.
pseudotuberculosis affects its virulence. De-
creased secretion of YopJ was shown to
enhance Y. pseudotuberculosis pathogenesis in
vivo [4]. Similarly for Y. pestis, enhanced
cytotoxicity results in decreased incidence
of pneumonic plague in vivo [5]. Tight
regulation of cytotoxicity by pathogenic
Yersinia is an efficient virulence strategy.
Increased apoptosis of infected immune
cells decreases production of proinflam-
matory cytokines; however, some inflam-
mation at the early stages of infection is
thought to facilitate tissue damage neces-
sary for movement of bacteria and infected
cells to other sites of replication within the
host [4].
Enteropathogenic Escherichia coli, enter-
ohaemorrhagic E. coli (EPEC and EHEC,
respectively), and Citrobacter rodentium are
attaching and effacing (A/E) pathogens
that cause severe diarrheagenic disease
[6]. The ability of A/E pathogens to kill
intestinal epithelial cells has been well
documented [7–14]. The type III secreted
(T3S) effector EspF has a role in host cell
death by causing mitochondrial-depen-
dent apoptosis [11,15]. We recently found
that the T3S effector EspZ modulates
cytotoxicity towards host cells. An EPEC
espZ mutant (DespZ) caused enhanced
cytotoxicity in host cells when compared
to the wild-type strain [16], which was
surprising since the DespZ strain is severely
attenuated for virulence in vivo [17]. EspZ
acts in part through the host transmem-
brane glycoprotein CD98 to activate focal
adhesion kinase (FAK)-based survival
pathways (Figure 1) [16]. Others found
that the T3S effector NleH also dampens
apoptosis of EPEC-infected cells, but via
interaction with a Bcl-2-related protein
involved in the mitochondrial death path-
way (Figure 1) [18]. Unlike EspZ, NleH is
not essential for EPEC colonization and
only moderately impacts on A/E patho-
gen disease in vivo [19,20]; however, there
are likely other host-protective virulence
factors that act redundantly to NleH
during EPEC infection.
H. pylori causes apoptosis of infected
gastric epithelial cells [21]. Apoptosis
induction by H. pylori has been linked to
a secreted toxin called VacA, which
induces cytochrome c release from mito-
chondria (Figure 1) [22]. Recently, it was
determined that VacA-mediated apoptosis
is counteracted by a type IV secreted
(T4S) protein called CagA by both block-
ing pinocytosis of VacA and inhibiting
VacA-mediated cytochrome c release from
mitochondria [23] (Figure 1). Interesting-
ly, loss of CagA in a VacA
+ H. pylori strain
decreases bacterial colonization and the
incidence of gastric hyperplasia, adeno-
carcinoma, and inflammation [24]. Simi-
lar to the aforementioned pathogens, H.
pylori has evolved a delicate interplay
between host-protective and -detrimental
virulence factors that are able to fine-
tune virulence while promoting their
propagation.
S. flexneri, the etiologic agent of bacilliary
dysentery, causes death of infected mac-
rophages and epithelial cells [25]. Despite
this, several host-protective strategies are
employed by S. flexneri. The T3S effector
OspE was recently found to enhance
adhesion of infected host cells to the
underlying extracellular matrix [26].
Whether OspE activates host cell survival
pathways directly is unknown; however, its
interaction with integrin-linked kinase
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intestinal lumen [26], consequently pre-
venting anoikis of Shigella-infected cells. An
ospE mutant does not colonize as efficiently
as wild-type S. flexneri in vivo; thus, OspE
may enhance colonization by preventing
premature release of infected cells [26].
Epithelial cells succumb to S. flexneri
infection via necrotic cell death, which
functions to release intracellular bacteria
and enhance inflammation [25]. Interest-
ingly, survival pathways involving Rip2/
IKKb/NFkB are activated early during
infection, followed by mitochondrial dys-
function and necrotic cell death (Figure 1)
[25]. The early expression of pro-survival
genes may enable S. flexneri to postpone
cell death in a similar manner to EPEC,
thus ensuring greater bacterial load prior
to dissemination. The mechanism(s) by
which S. flexneri enhances NFkB-mediated
pro-survival signals are unknown.
All of the above pathogens have evolved
strategies to attenuate their own host-
damaging virulence factors. In many of
these scenarios, removal of host-protective
mediators actually reduces pathogenicity
of the bacteria. The observation that
EPEC encodes a host-protective virulence
factor that is essential for its pathogenesis
suggests that protecting host cells may be a
key to the pathogenic strategies of other
bacterial pathogens. The concept of host-
protective virulence factors is only just
emerging, and we believe host-protective
virulence factors will become more appar-
ent in other pathogenic strategies and may
become interesting targets to combat
bacterial disease. Importantly, virulence
phenotypes that appear counterintuitive
should not be ignored. Future studies into
pathogenic mechanisms of virulent bacte-
ria will likely reveal important roles for
effectors or regulatory mechanisms that
help the host cell and promote bacterial
pathogenesis.
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